FDA authorizes Pfizer’s Paxlovid pill as first at-home COVID treatment
SILVER SPRINGS, MD, December 22, 2021 – Today, the Food and Drug Administration authorized Pfizer’s Paxlovid for adults and children ages 12 and older with a positive COVID-19 test and early symptoms who face the highest risks of hospitalization. Children eligible for the drug must weigh at least 88 pounds. Paxlovid, is an alternative treatment […]
Pfizer booster now recommended for 16-year-olds and up
SNOHOMISH COUNTY, Wash., December 10, 2021 – Following announcements by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), Pfizer boosters are now recommended for everyone 16-17 years of age who received their second dose of Pfizer at least six months ago. In addition, everyone 18 and older is recommended to get […]
